These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10078661)

  • 21. A breakthrough in the genetic diagnosis of malignant hyperthermia.
    Robinson RL; Hopkins PM
    Br J Anaesth; 2001 Feb; 86(2):166-8. PubMed ID: 11573654
    [No Abstract]   [Full Text] [Related]  

  • 22. Spontaneous occurrence of the disposition to malignant hyperthermia.
    Rueffert H; Olthoff D; Deutrich C
    Anesthesiology; 2004 Mar; 100(3):731-3. PubMed ID: 15108991
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant hyperthermia: advances in clinical management and diagnosis.
    Hopkins PM
    Br J Anaesth; 2000 Jul; 85(1):118-28. PubMed ID: 10928000
    [No Abstract]   [Full Text] [Related]  

  • 24. Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.
    Hernandez JF; Secrest JA; Hill L; McClarty SJ
    J Perianesth Nurs; 2009 Feb; 24(1):19-31; quiz 32-4. PubMed ID: 19185818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant hyperthermia: difficulty in diagnosing susceptibility in Spain].
    Montes A; Ramos R; Trillo L; Silva T; Puig MM
    Rev Esp Anestesiol Reanim; 1999 Mar; 46(3):130-2. PubMed ID: 10228380
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
    Sorosky JI; Ingardia CJ; Botti JJ
    Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant hyperthermia: case-finding of subjects at risk].
    Viering WA; Sengers RC; Stadhouders AM; Gielen MJ; Festen C
    Ned Tijdschr Geneeskd; 1986 May; 130(22):1002-4. PubMed ID: 3724881
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant hyperthermia.
    Sessler DI
    Acta Anaesthesiol Scand Suppl; 1996; 109():25-30. PubMed ID: 8901933
    [No Abstract]   [Full Text] [Related]  

  • 29. The genetics of malignant hyperthermia: evidence for heterogeneity.
    McPherson E; Taylor CA
    Am J Med Genet; 1982 Mar; 11(3):273-85. PubMed ID: 7081293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hyperthermia--a clinical review.
    Haddad FS
    Middle East J Anaesthesiol; 1986 Oct; 8(6):469-85. PubMed ID: 3537672
    [No Abstract]   [Full Text] [Related]  

  • 32. Current diagnostic methods of malignant hyperthermia: an evaluation.
    Ording H
    Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
    [No Abstract]   [Full Text] [Related]  

  • 33. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant hyperthermia: a pharmacogenetic disorder.
    Stratman RC; Flynn JD; Hatton KW
    Orthopedics; 2009 Nov; 32(11):835. PubMed ID: 19902883
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolonged malignant hyperthermia in the absence of triggering agents.
    Pollock N; Hodges M; Sendall J
    Anaesth Intensive Care; 1992 Nov; 20(4):520-3. PubMed ID: 1463189
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA analysis and malignant hyperthermia susceptibility.
    Stowell KM; Pollock N
    Anaesth Intensive Care; 2008 May; 36(3):305-7. PubMed ID: 18564791
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?
    Robinson RL; Anetseder MJ; Brancadoro V; van Broekhoven C; Carsana A; Censier K; Fortunato G; Girard T; Heytens L; Hopkins PM; Jurkat-Rott K; Klinger W; Kozak-Ribbens G; Krivosic R; Monnier N; Nivoche Y; Olthoff D; Rueffert H; Sorrentino V; Tegazzin V; Mueller CR
    Eur J Hum Genet; 2003 Apr; 11(4):342-8. PubMed ID: 12700608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia and pediatric urology.
    Sipio JC; Bellinger MF
    J Urol; 1986 Mar; 135(3):583-5. PubMed ID: 3944913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of malignant hyperthermia.
    Ball SP; Johnson KJ
    J Med Genet; 1993 Feb; 30(2):89-93. PubMed ID: 8383206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.